Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Addrenex Pharmaceuticals

Latest From Addrenex Pharmaceuticals

Locate Bio Joins UK Biomaterials Innovators Addressing Unmet Orthopedic Surgery Needs

Since its September 2021 $13m (£10m) funding round, Locate Bio has continued the development of its range of orthobiologics focused on improving outcomes from orthopedic surgery.

Innovation Regenerative Medicine

VC Roundup: Three New Funds Close As Small, Early Financings Bounce Back

Even Series A rounds have been large during recent record-breaking years for biotech venture capital investment, but it looks like smaller financings for early-stage companies may be in the midst of a comeback. With VC firms closing new funds, that raises the question: Will the number of preclinical and Phase I financings increase?

Companies Business Strategies

Acorda completes Neuronex acquisition as diazepam nasal spray nears NDA

Acorda Therapeutics paid $6.8 million on 20 December to complete the acquisition of Neuronex and the Ardsley, New York-based company will make up to $134 million in additional milestone payments plus royalties for Neuronex's patient-friendly intranasal formulation of diazepam for the control of acute repetitive seizures (ARS).

Neurology Immune Disorders

Beyond INFUSE: Spine Community Searches For Answers, Alternatives

Medtronic's INFUSE bone morphogenetic protein is the only product in the musculoskeletal industry that has changed the bar in terms of bone healing, and it is under fire for complications related to off-label use. As regulators and payors crack down on INFUSE and hospitals restrict access to the product, surgeons are seeking alternatives and there are a number of companies lining up to fill the void

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals